By using WellRx, you accept our Privacy Policy (including the CA Privacy Act policy if you are a CA resident), including our collection of data and use of cookies.

  • No image available for this medication
    • LISRAYA

BREPOCITINIB (BREP oh SYE ti nib) treats dermatomyositis, an autoimmune condition that causes muscle weakness and skin rash. It works by slowing down an overactive immune system. This decreases symptoms.


LISRAYA Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.